Skip to main content
Does knowing ischemic stroke subtypes among SLE patients matter?
This study by Hopia et al 👉54% of ischemic strokes

sheila

2 years 9 months ago
Does knowing ischemic stroke subtypes among SLE patients matter? This study by Hopia et al 👉54% of ischemic strokes in 56 SLE pts were APS/aPL & cardioembolic origin (accdg to TOAST) & +assoc with STAT4 gene. #ACR23 ABST0579 @RheumNow https://t.co/Ut8QPpQNQp
Can a picture tell a RA swollen joint?
(would be super useful for telehealth/remote monitor if so)

It's not prime time

David Liew drdavidliew

2 years 9 months ago
Can a picture tell a RA swollen joint? (would be super useful for telehealth/remote monitor if so) It's not prime time yet, but following with interest: using photos to pick up on skin folds/joint swelling Fascinating, but let's see it vs MRI, clinical #ACR23 ABST0402 @RheumNow https://t.co/TFKiD5J4c8
We gotta do better! Reproductive health counseling is poorly done- only a third rheumatologists surveyed ask pts about r

TheDaoIndex KDAO2011

2 years 9 months ago
We gotta do better! Reproductive health counseling is poorly done- only a third rheumatologists surveyed ask pts about reproductive health: sexual activity, pregnancy desire, contraception. Abstr#0162 @_michgarcia @rheumnow #ACR23 https://t.co/r9tewu2I9N
Smartwatches to measures axSpA activity?
Upadacitinib use in axSpA INCREASED physical activity based on a wearable medic

Robert B Chao, MD

2 years 9 months ago
Smartwatches to measures axSpA activity? Upadacitinib use in axSpA INCREASED physical activity based on a wearable medical device step count, especially in those who were originally sedentary. @RheumNow #ACR23 Abs#0530 #ACRbest https://t.co/oOFiQwMFZ6
SLE pts with +aCL IgG/IgM and LA had higher risk of developing atherosclerotic CVD accdg to this prospective study by Di

sheila

2 years 9 months ago
SLE pts with +aCL IgG/IgM and LA had higher risk of developing atherosclerotic CVD accdg to this prospective study by Ding et al. . . . 🧐Again, SLE pts have ⬆️CV risk so always risk stratify and intervene early. #ACR23 ABST0552 @RheumNow https://t.co/QhttQZzp8G
Year in Review by Dr. P Seo

NORD-STAR trial:
⭐️Abatacept or Certolizumab >> Tociluzumab > triple therap

Meral K. El Ramahi, MD MeralElRamahiMD

2 years 9 months ago
Year in Review by Dr. P Seo NORD-STAR trial: ⭐️Abatacept or Certolizumab >> Tociluzumab > triple therapy in tx of 812 early RA patients based on clinical & radiographic results ➡️tx-naive, all got MTX ➡️mod-sev dz activity ➡️randomized to 48 wks therapy #ACR23 @RheumNow https://t.co/vy2uYuyOse
Interesting question... but feels like some time related bias or perhaps confounding?

Seems implausible that MTX &

Mike Putman EBRheum

2 years 9 months ago
Interesting question... but feels like some time related bias or perhaps confounding? Seems implausible that MTX & biologic would be protective for PsO & harmful for PsA @RheumNow #ACR23 Abstr 0498 https://t.co/pSRoLHRTAm
NAFLD a real issue in RA
Does DMARD choice matter?

National Taiwanese data
newly dx RA n=41791

HCQ reduced NAFLD risk:

David Liew drdavidliew

2 years 9 months ago
NAFLD a real issue in RA Does DMARD choice matter? National Taiwanese data newly dx RA n=41791 HCQ reduced NAFLD risk: adjHR 0.75 (other RF: obesity, NSAIDs, even low-dose PNL; but not DM, MTX) Can HCQ improve liver health in RA? Authors: ?adiponectin #ACR23 ABST0396 @RheumNow https://t.co/9VMJpImFKs
C-VIEW study on certolizumab use in preventing anterior uveitis in high risk pts with axSpA.
All pts were B27+ w/ at lea

Robert B Chao, MD

2 years 9 months ago
C-VIEW study on certolizumab use in preventing anterior uveitis in high risk pts with axSpA. All pts were B27+ w/ at least one episode of anterior uveitis Uveitis flares lower in certolizumab group compared to non-bDMARD use @RheumNow #ACR23 Abs#0524 https://t.co/CfnhzStBMv
This study by Munoz-Grajales et al show that the analyte S100A8/A9 (highest AUC) was able to differentiate between SLE p

sheila

2 years 9 months ago
This study by Munoz-Grajales et al show that the analyte S100A8/A9 (highest AUC) was able to differentiate between SLE pts with cognitive impairment and those without. . . . Interesting findings. More data needed to confirm and explain why it is so. #ACR23 ABST0558 @RheumNow https://t.co/LcF6s2qgNr
PROs are useful for tracking RA disease activity over time outside of the clinic setting for patients initiating new tre

Dr. Antoni Chan

2 years 9 months ago
PROs are useful for tracking RA disease activity over time outside of the clinic setting for patients initiating new treatments without clinician-derived measures. Correlations in follow-up CDAI and PROs were 0.38 – 0.56, Nowell Abst#0380 #ACR23 @RheumNow https://t.co/LepCZ7sPY8 https://t.co/UYcZzIFEsx
#CV risk in #AxSpA in Korean population study N=71001, age 42, 71%M but 16% #MTX, 58% #SSZ. #TNFi vs none 30% less CVE.

Janet Pope

2 years 9 months ago
#CV risk in #AxSpA in Korean population study N=71001, age 42, 71%M but 16% #MTX, 58% #SSZ. #TNFi vs none 30% less CVE. IL17 NO CV reduction but ?confounded by line of #Rx and v large N for TNFi. Study stated PRIOR to IL17i approval #ACR23 @ACRheum @RheumNow L11 poster ?Rx bias https://t.co/3Sft5KUlLa
Nice VA study evaluating risk of lung cancer w/respect to RA treatment strategies

Take home? No association. Aside from

Mike Putman EBRheum

2 years 9 months ago
Nice VA study evaluating risk of lung cancer w/respect to RA treatment strategies Take home? No association. Aside from the (small risk) w/JAKi's, I think malignancy risks have been mostly overblown @NamrataRheum @RheumNow ABST0453 #ACR23 https://t.co/lDz0nV1KHt
Low-grade troponin rises in RA: ignore, or meaningful?

@BrighamWomens RA pts n=329
baseline hs-cTnT

Trops actually pre

David Liew drdavidliew

2 years 9 months ago
Low-grade troponin rises in RA: ignore, or meaningful? @BrighamWomens RA pts n=329 baseline hs-cTnT Trops actually predict MACE: HR 6.62 independent of traditional CV risk, CRP Traditional CV RF not enough in RA Maybe smoke does predict future fire? #ACR23 ABST0387 @RheumNow https://t.co/33ZCgzYIl4
Let’s talk about SEX! >30% of pts wished their rheums asked them about sexual health, >50% pts with sexual dysf

TheDaoIndex KDAO2011

2 years 9 months ago
Let’s talk about SEX! >30% of pts wished their rheums asked them about sexual health, >50% pts with sexual dysfunction have RA. The presence of menopause, younger age, and children were assc with sexual dysfunction. presenter Dr D Flores Abstr#0145, #abst#0146 #ACR23 @RheumNow https://t.co/9AdoTtEwFp
×